Unrestricted Use of 2 New-Generation Drug-Eluting Stents in Patients With Acute Myocardial Infarction A Propensity Score-Matched Analysis
- Authors
- Chen, Kang-Yin; Rha, Seung-Woon; Wang, Lin; Li, Yong-Jian; Li, Guang-Ping; Poddar, Kanhaiya L.; Park, Ji-Young; Choi, Cheol Ung; Park, Chang-Gyu; Seo, Hong Seog; Oh, Dong Joo; Jeong, Myung Ho; Ahn, Young Keun; Hong, Taek Jong; Kim, Young Jo; Hur, Seung Ho; Seong, In Whan; Chae, Jei Keon; Cho, Myeong Chan; Bae, Jang Ho; Choi, Dong Hoon; Jang, Yang Soo; Chae, In Ho; Kim, Chong Jin; Yoon, Jung Han; Chung, Wook Sung; Seung, Ki Bae; Park, Seung Jung
- Issue Date
- Sep-2012
- Publisher
- ELSEVIER SCIENCE INC
- Keywords
- acute myocardial infarction; everolimus-eluting stents; percutaneous coronary intervention; zotarolimus-eluting stents
- Citation
- JACC-CARDIOVASCULAR INTERVENTIONS, v.5, no.9, pp.936 - 945
- Indexed
- SCIE
SCOPUS
- Journal Title
- JACC-CARDIOVASCULAR INTERVENTIONS
- Volume
- 5
- Number
- 9
- Start Page
- 936
- End Page
- 945
- URI
- https://scholar.korea.ac.kr/handle/2021.sw.korea/107488
- DOI
- 10.1016/j.jcin.2012.05.009
- ISSN
- 1936-8798
- Abstract
- Objectives This study sought to compare everolimus-eluting stents (EES) with zotarolimus-eluting stents (ZES) in patients with acute myocardial infarction (AMI). Background There is a paucity of data to exclusively evaluate the safety and efficacy of second-generation drug-eluting stents (DES) in the setting of AMI. Methods The present study enrolled 3,309 AMI patients treated with ZES (n = 1,608) or EES (n = 1,701) in a large-scale, prospective, multicenter registry-KAMIR (Korea Acute Myocardial Infarction Registry). Propensity score matching was applied to adjust for differences in baseline clinical and angiographic characteristics, producing a total of 2,646 patients (1,343 receiving ZES, and 1,343 receiving EES). Target lesion failure (TLF) was defined as the composite of cardiac death, recurrent nonfatal myocardial infarction, or target lesion revascularization. Major clinical outcomes at 1 year were compared between the 2 propensity score-matched groups. Results After propensity score matching, baseline clinical and angiographic characteristics were similar between the 2 groups. Clinical outcomes of the propensity score-matched patients showed that, despite similar incidences of recurrent nonfatal myocardial infarction and in-hospital and 1-year mortality, patients in the EES group had significantly lower rates of TLF (6.5% vs. 8.7%, p = 0.029) and probable or definite stent thrombosis (0.3% vs. 1.6%, p < 0.001), compared with those in the ZES group. Furthermore, there was a numerically lower rate of target lesion revascularization (1.2% vs. 2.2%, p = 0.051) in the EES group than in the ZES group. Conclusions In this propensity-matched comparison, EES seems to be superior to ZES in reducing TLF and stent thrombosis in patients with AMI. (J Am Coll Cardiol Intv 2012;5:936-45) (C) 2012 by the American College of Cardiology Foundation
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Graduate School > Department of Biomedical Sciences > 1. Journal Articles
- College of Medicine > Department of Medical Science > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholar.korea.ac.kr/handle/2021.sw.korea/107488)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.